AR067176A1 - Compuesto de benzazepina y preparacion farmaceutica - Google Patents

Compuesto de benzazepina y preparacion farmaceutica

Info

Publication number
AR067176A1
AR067176A1 ARP080102749A ARP080102749A AR067176A1 AR 067176 A1 AR067176 A1 AR 067176A1 AR P080102749 A ARP080102749 A AR P080102749A AR P080102749 A ARP080102749 A AR P080102749A AR 067176 A1 AR067176 A1 AR 067176A1
Authority
AR
Argentina
Prior art keywords
group
optionally substituted
atom
alkyl group
hydroxy
Prior art date
Application number
ARP080102749A
Other languages
English (en)
Spanish (es)
Inventor
Yusuke Kato
Kazumi Kondo
Takakuni Matsuda
Shin Miyamura
Keigo Yamada
Yasuhiro Menjo
Yuso Tomohira
Takahiro Tomoyasu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR067176A1 publication Critical patent/AR067176A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C07F9/5535—Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP080102749A 2007-06-26 2008-06-26 Compuesto de benzazepina y preparacion farmaceutica AR067176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007167207 2007-06-26

Publications (1)

Publication Number Publication Date
AR067176A1 true AR067176A1 (es) 2009-09-30

Family

ID=39773045

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102749A AR067176A1 (es) 2007-06-26 2008-06-26 Compuesto de benzazepina y preparacion farmaceutica

Country Status (27)

Country Link
US (3) US8669229B2 (OSRAM)
EP (3) EP2374797B1 (OSRAM)
JP (3) JP5653043B2 (OSRAM)
KR (1) KR101487201B1 (OSRAM)
CN (3) CN101687805A (OSRAM)
AR (1) AR067176A1 (OSRAM)
AT (1) ATE545633T1 (OSRAM)
AU (1) AU2008269918B2 (OSRAM)
BR (1) BRPI0813768A2 (OSRAM)
CA (1) CA2690335A1 (OSRAM)
CO (1) CO6160295A2 (OSRAM)
CY (3) CY1113519T1 (OSRAM)
DK (3) DK2374797T3 (OSRAM)
ES (3) ES2431515T3 (OSRAM)
HR (3) HRP20120310T1 (OSRAM)
IL (1) IL202561A0 (OSRAM)
MY (3) MY152805A (OSRAM)
NZ (3) NZ598064A (OSRAM)
PH (2) PH12012501362A1 (OSRAM)
PL (3) PL2170831T3 (OSRAM)
PT (3) PT2170831E (OSRAM)
RU (1) RU2471784C2 (OSRAM)
SG (2) SG182230A1 (OSRAM)
SI (3) SI2374798T1 (OSRAM)
TW (1) TWI459947B (OSRAM)
UA (1) UA98966C2 (OSRAM)
WO (1) WO2009001968A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
JP5656399B2 (ja) * 2008-12-26 2015-01-21 大塚製薬株式会社 医薬及び医薬製剤
CN102030709B (zh) * 2009-09-25 2013-10-16 江苏豪森医药集团有限公司 用作加压素受体拮抗剂的苯并氮杂卓类化合物
SG10201406839VA (en) * 2009-10-26 2014-12-30 Otsuka Pharma Co Ltd Benzazepine compound
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
CN102260213B (zh) * 2011-05-31 2013-05-15 重庆福安药业(集团)股份有限公司 一种托伐普坦的制备方法
TWI704919B (zh) 2012-05-31 2020-09-21 日商大塚製藥股份有限公司 用於預防及/或治療多囊性腎臟病之藥物
WO2014104412A1 (en) * 2012-12-28 2014-07-03 Otsuka Pharmaceutical Co., Ltd. Injectable depot formulation comprising optically active tolvaptan and process of producing the same
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
TWI660748B (zh) * 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
US11911369B2 (en) * 2015-03-03 2024-02-27 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use
WO2019003433A1 (ja) * 2017-06-30 2019-01-03 大塚製薬株式会社 ベンゾアゼピン誘導体
CN107540672A (zh) * 2017-10-10 2018-01-05 牡丹江医学院 一种治疗肝硬化的药物及其合成方法
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
JP2020011957A (ja) * 2019-07-22 2020-01-23 コルセア ファーマ インコーポレイテッド トレプロスチニル誘導体化合物およびその使用方法
CN112851583B (zh) * 2021-01-19 2023-09-08 徐州医科大学 新型苯并氮杂䓬类化合物、组合物及其用途
AU2022219348A1 (en) * 2021-02-10 2023-09-21 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Benzazepine compounds, preparation method therefor and pharmaceutical use thereof
CN113112528A (zh) * 2021-04-26 2021-07-13 中南财经政法大学 异常行为监控方法、装置、设备及存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045478A (en) * 1986-03-03 1991-09-03 Becton Dickinson And Company Vesicles and use thereof in an assay
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
TW249201B (OSRAM) * 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
TW270927B (OSRAM) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
GB9726695D0 (en) * 1997-12-17 1998-02-18 Smithkline Beecham Plc Novel compounds
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
PT1117659E (pt) * 1998-09-29 2004-04-30 Wyeth Corp Cianoquinolinas substituidas como inibidores de tirosina-quinases de proteinas
ATE264295T1 (de) * 2000-05-15 2004-04-15 Paratek Pharm Innc 7-substituierte kondensierte ring-tetrazyclin- verbindungen
WO2006050421A1 (en) * 2004-11-02 2006-05-11 New River Pharmaceuticals Inc. Prodrugs of ribavirin with improved hepatic delivery
AU2006330277B2 (en) * 2005-12-27 2011-10-06 Otsuka Pharmaceutical Co., Ltd. Water-soluble benzoazepine compound and its pharmaceutical composition
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑

Also Published As

Publication number Publication date
PH12012501362A1 (en) 2014-04-28
SI2374797T1 (sl) 2014-05-30
CY1113519T1 (el) 2016-06-22
NZ581723A (en) 2012-03-30
SI2374798T1 (sl) 2013-10-30
DK2374797T3 (da) 2014-05-12
MY150941A (en) 2014-03-14
US20140024619A1 (en) 2014-01-23
UA98966C2 (ru) 2012-07-10
JP2010531293A (ja) 2010-09-24
TWI459947B (zh) 2014-11-11
KR101487201B1 (ko) 2015-01-28
PT2374797E (pt) 2014-05-02
NZ598067A (en) 2012-12-21
PT2374798E (pt) 2013-11-05
AU2008269918B2 (en) 2012-12-06
PL2374798T3 (pl) 2014-01-31
DK2170831T3 (da) 2012-05-21
EP2374798B1 (en) 2013-09-04
CA2690335A1 (en) 2008-12-31
PH12012501363A1 (en) 2014-04-28
US8785386B2 (en) 2014-07-22
CO6160295A2 (es) 2010-05-20
EP2374797A1 (en) 2011-10-12
JP5893085B2 (ja) 2016-03-23
CY1115226T1 (el) 2017-01-04
PT2170831E (pt) 2012-04-13
CY1114491T1 (el) 2016-10-05
US8669229B2 (en) 2014-03-11
JP5653043B2 (ja) 2015-01-14
MY152805A (en) 2014-11-28
KR20100040873A (ko) 2010-04-21
US20140024640A1 (en) 2014-01-23
NZ598064A (en) 2013-04-26
TW200911271A (en) 2009-03-16
RU2471784C2 (ru) 2013-01-10
HK1141994A1 (en) 2010-11-26
SI2170831T1 (sl) 2012-04-30
CN103342680A (zh) 2013-10-09
MY148312A (en) 2013-03-29
PL2170831T3 (pl) 2012-08-31
BRPI0813768A2 (pt) 2014-12-30
EP2374797B1 (en) 2014-03-26
ES2431515T3 (es) 2013-11-26
JP5689195B2 (ja) 2015-03-25
JP2014205703A (ja) 2014-10-30
SG182230A1 (en) 2012-07-30
EP2170831B1 (en) 2012-02-15
HRP20140501T1 (hr) 2014-07-04
HK1163077A1 (en) 2012-09-07
WO2009001968A1 (en) 2008-12-31
HRP20131095T1 (hr) 2014-01-03
US20110071084A1 (en) 2011-03-24
HRP20120310T1 (hr) 2012-06-30
JP2014208680A (ja) 2014-11-06
HK1163660A1 (en) 2012-09-14
CN103342679A (zh) 2013-10-09
AU2008269918A1 (en) 2008-12-31
PL2374797T3 (pl) 2014-08-29
CN101687805A (zh) 2010-03-31
ATE545633T1 (de) 2012-03-15
US9073868B2 (en) 2015-07-07
IL202561A0 (en) 2010-06-30
ES2460018T3 (es) 2014-05-13
DK2374798T3 (da) 2013-10-07
RU2010102229A (ru) 2011-08-10
EP2374798A1 (en) 2011-10-12
ES2380085T3 (es) 2012-05-08
SG182231A1 (en) 2012-07-30
EP2170831A1 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
AR067176A1 (es) Compuesto de benzazepina y preparacion farmaceutica
ECSP099638A (es) Nuevo compuesto de adenina
AR077141A1 (es) Derivados de 4-aminopicolatos sustituidos, procesos de preparacion y composiciones herbicidas que lo comprenden
CY1123308T1 (el) Αναστολεας ινωσης
AR064246A1 (es) Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer.
ECSP11011189A (es) Moduladores de los receptores tipo toll
PE20170438A1 (es) Inhibidores espirociclicos de catepsina c
PE20121358A1 (es) Derivados de indol como inhibidores itk
AR063912A1 (es) Derivados de 1,2,4 oxadiazol. composiciones farmaceuticas.
DOP2010000046A (es) Compuestos de biciclolactama sustituida
AR088029A1 (es) Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central
AR079401A1 (es) Cianobutiratos sustituidos con accion herbicida
AR074782A1 (es) Antranilamidas sustituidas con tetrazol como plaguicidas
AR079231A1 (es) Derivados de imidazoquinolina
ES2630079T3 (es) Moduladores de la ruta del complemento y usos de los mismos
AR086296A1 (es) Derivados de dihidroisoxasol utiles como parasiticidas tanto en animales como en plantas
PE20120172A1 (es) Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide
AR083199A1 (es) Compuestos de n-heteroarilo con unidad de puente ciclico
AR078152A1 (es) Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden
AR079553A1 (es) Derivados de diaza-espiro-[5,5]-undecanos, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos del snc, tales como trastornos del sueno y de la dependencia,entre otros.
AR081252A1 (es) Compuestos para el tratamiento del sindrome metabolico
SV2010003459A (es) Derivados de pirimidina 934
CR8756A (es) Derivados de acido carboxilico bencimidazolona
AR085333A1 (es) Derivados de pirazol microbicidas
PE20140649A1 (es) Derivado de macrolido sustituido en la posicion c4

Legal Events

Date Code Title Description
FB Suspension of granting procedure